Spain – Pharmaceutical products – 2 Prorroga-Suministro de VUTRISIRAN (AMVUTTRA 25 mg solución inyectable jeringa) de di
Hospital Clínico San Carlos de Madrid awarded €2.9M to ALNYLAM PHARMACEUTICALS SPAIN, S.L. for Construction & Public Works in July 2025 — one of 764 awards this buyer has made, above its typical award size.
Buying agency
Hospital Clínico San Carlos de MadridWinning supplier
ALNYLAM PHARMACEUTICALS SPAIN, S.L.Contract description
Spain – Pharmaceutical products – 2 Prorroga-Suministro de VUTRISIRAN (AMVUTTRA 25 mg solución inyectable jeringa) de distribución exclusiva, con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
Related awards · Hospital Clínico San Carlos de Madrid
764 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-501647-2026ALNYLAM PHARMACEUTICALS SPAIN, S.L.€2.9M21 Jul 2026 Construction
- ocds-ted-73449-2025ALNYLAM PHARMACEUTICALS SPAIN, S.L.€2.9M03 Feb 2025 Construction
- ocds-ted-80131-2026ALNYLAM PHARMACEUTICALS SPAIN, S.L.€2.9M04 Feb 2026 Construction
Other wins · ALNYLAM PHARMACEUTICALS SPAIN, S.L.
43 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-675384-2024Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez€14.8M06 Nov 2024 Construction
- ocds-ted-447588-2025Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau€8.4M09 Jul 2025 Construction
- ocds-ted-158957-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€7.3M15 Mar 2024 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Hospital Clínico San Carlos de Madrid and ALNYLAM PHARMACEUTICALS SPAIN, S.L. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back